West Pharmaceutical Services (WST) Tax Provisions (2009 - 2026)

West Pharmaceutical Services (WST) has 18 years of Tax Provisions data on file, last reported at $44.7 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 85.48% year-over-year to $44.7 million; the trailing twelve-month figure through Mar 2026 stood at $142.2 million (up 23.44% YoY), and the FY2025 full-year result was $121.6 million, up 13.12% from the prior year.
• Tax Provisions improved to $44.7 million in Q1 2026, from $33.3 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $44.7 million in Q1 2026 to a low of $16.4 million in Q1 2024.
• A 5-year average of $30.0 million and a median of $30.2 million in 2025 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions plunged 37.07% in 2024 and surged 85.48% in 2026, its largest moves.
• Tracing WST's Tax Provisions over 5 years: stood at $28.9 million in 2022, then grew by 19.38% to $34.5 million in 2023, then increased by 6.67% to $36.8 million in 2024, then slipped by 9.51% to $33.3 million in 2025, then jumped by 34.23% to $44.7 million in 2026.
• Business Quant data shows WST's Tax Provisions at $44.7 million in Q1 2026, $33.3 million in Q4 2025, and $34.0 million in Q3 2025.